Cancer Research CTRC-AACR San Antonio Breast Cancer Symposium  Tumor Immunology: New Perspectives
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Cancer Research Clinical Cancer Research
Cancer Epidemiology Biomarkers & Prevention Molecular Cancer Therapeutics
Molecular Cancer Research Cancer Prevention Research
Cancer Prevention Journals Portal Cancer Reviews Online
Annual Meeting Education Book Meeting Abstracts Online

[Cancer Research 51, 1680-1683, March 15, 1991]
© 1991 American Association for Cancer Research

This Article
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Wilke, A. V.
Right arrow Articles by Frazier, D. L.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Wilke, A. V.
Right arrow Articles by Frazier, D. L.

Effect of Hyperthermia on Normal Tissue Toxicity and on Adriamycin Pharmacokinetics in Dogs

A. V. Wilke, C. Jenkins, A. J. Milligan, A. Legendre and D. L. Frazier1

College of Veterinary Medicine, Departments of Environmental Practice [A. V. W., D. L. F.] and Urban Practice [C. J., A. J. M., A. L.], University of Tennessee, Knoxville, Tennessee 37901-1071

This study examined the effects of Adriamycin (ADR) (30 mg/m2), whole-body hyperthermia (WBH) (42°C for 1 h), and the combination of the two (ADR plus WBH) on gastrointestinal and hematopoietic toxicity and the effects of WBH on ADR pharmacokinetics in the normal dog (n = 5/treatment group).

Duodenal biopsies were collected from animals in each group via endoscopy and were incubated in the presence of [3H]thymidine as an index of cell turnover. Additional duodenal biopsies were assayed for the enzymes {gamma}-glutamyltranspeptidase, N-acetyl-ß-D-glucosaminidase, and succinate dehydrogenase. Complete blood chemistry profiles and differential blood cell counts were done prior to and following treatment. Cell turnover was most depressed 3 days after ADR or ADR plus WBH; WBH alone had little effect on cell turnover. Neither {gamma}-glutamyltrans-peptidase, N-acetyl-ß-D-glucosaminidase, nor succinate dehydrogenase activities were significantly altered by any of the treatment protocols.

High performance liquid chromatography was used to quantify Adriamycin and adriamycinol in samples collected up to 6 h after drug administration. Duodenal biopsies were collected immediately and 1 h after drug administration for measurement of tissue concentrations of Adriamycin. A significant increase in the apparent volume of distribution and whole-body clearance and decrease in area under the plasma Adriamycin concentration versus time curve occurred when drug was administered concurrently with WBH. This differs from results reported in some other mammalian species.

1 To whom requests for reprints should be addressed, at College of Veterinary Medicine, Department of Environmental Practice, University of Tennessee, P.O. Box 1071, Knoxville, TN 37901-1071.

Received 9/25/90. Accepted 1/ 9/91.




This article has been cited by other articles:


Home page
Clin. Cancer Res.Home page
S. Hegewisch-Becker, K. Braun, M. Otte, A. Corovic, D. Atanackovic, A. Nierhaus, D. K. Hossfeld, and K. Pantel
Effects of Whole Body Hyperthermia (41.8{degrees}C) on the Frequency of Tumor Cells in the Peripheral Blood of Patients with Advanced Malignancies
Clin. Cancer Res., June 1, 2003; 9(6): 2079 - 2084.
[Abstract] [Full Text] [PDF]


Home page
Ann OncolHome page
S. Hegewisch-Becker, Y. Gruber, A. Corovic, U. Pichlmeier, D. Atanackovic, A. Nierhaus, and D. K. Hossfeld
Whole-body hyperthermia (41.8{degrees}C) combined with bimonthly oxaliplatin, high-dose leucovorin and 5-fluorouracil 48-hour continuous infusion in pretreated metastatic colorectal cancer: a phase II study
Ann. Onc., August 1, 2002; 13(8): 1197 - 1204.
[Abstract] [Full Text] [PDF]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Cancer Research Clinical Cancer Research
Cancer Epidemiology Biomarkers & Prevention Molecular Cancer Therapeutics
Molecular Cancer Research Cancer Prevention Research
Cancer Prevention Journals Portal Cancer Reviews Online
Annual Meeting Education Book Meeting Abstracts Online
Copyright © 1991 by the American Association for Cancer Research.